Epigenetic Age in Peripheral Blood Among Children, Adolescent, and Adult Survivors of Childhood Cancer

IMPORTANCE: Certain cancer therapies are risk factors for epigenetic age acceleration (EAA) among survivors of childhood cancer, and EAA is associated with chronic health conditions (CHCs). However, small numbers of younger survivors (aged <20 years) previously evaluated have limited the ability...

Descripción completa

Detalles Bibliográficos
Autores principales: Plonski, Noel-Marie, Chen, Cheng, Dong, Qian, Qin, Na, Song, Nan, Parikh, Hemang M., Shelton, Kyla, Finch, Emily R., Easton, John, Mulder, Heather, Zhang, Jinghui, Neale, Geoffrey, Walker, Emily, Wang, Hui, Krull, Kevin, Ness, Kirsten K., Hudson, Melissa M., Robison, Leslie L., Li, Qian, Williams, AnnaLynn, Wang, Zhaoming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148192/
https://www.ncbi.nlm.nih.gov/pubmed/37115548
http://dx.doi.org/10.1001/jamanetworkopen.2023.10325

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148192/
https://www.ncbi.nlm.nih.gov/pubmed/37115548
http://dx.doi.org/10.1001/jamanetworkopen.2023.10325

Ejemplares similares